Last reviewed · How we verify
WHO recommended 2011 Influenza vacccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
WHO recommended 2011 Influenza vacccine (WHO recommended 2011 Influenza vacccine) — Tel-Aviv Sourasky Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| WHO recommended 2011 Influenza vacccine TARGET | WHO recommended 2011 Influenza vacccine | Tel-Aviv Sourasky Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- WHO recommended 2011 Influenza vacccine CI watch — RSS
- WHO recommended 2011 Influenza vacccine CI watch — Atom
- WHO recommended 2011 Influenza vacccine CI watch — JSON
- WHO recommended 2011 Influenza vacccine alone — RSS
Cite this brief
Drug Landscape (2026). WHO recommended 2011 Influenza vacccine — Competitive Intelligence Brief. https://druglandscape.com/ci/who-recommended-2011-influenza-vacccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab